IR Biosciences Holdings, Inc.
IRBS
$0.00
$0.000.00%
OTC PK
| 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | 12/31/2009 | |
|---|---|---|---|---|---|
| Net Income | -5.28M | -4.20M | -4.44M | -7.65M | -6.46M |
| Total Depreciation and Amortization | 8.30K | 9.20K | 10.50K | 10.60K | 13.70K |
| Total Amortization of Deferred Charges | 1.04M | 954.70K | 1.13M | 1.10M | 1.08M |
| Total Other Non-Cash Items | 1.92M | 946.20K | 778.20K | 3.81M | 2.42M |
| Change in Net Operating Assets | 1.88M | 1.51M | 1.05M | 509.70K | 76.00K |
| Cash from Operations | -430.30K | -786.80K | -1.47M | -2.22M | -2.88M |
| Capital Expenditure | -- | 0.00 | 0.00 | 0.00 | -1.50K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 0.00 | 0.00 | -1.50K |
| Total Debt Issued | 150.00K | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 150.00K | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -280.30K | -786.80K | -1.47M | -2.22M | -2.88M |